Trial Profile
Clinical Trial to Investigate the Influence of SK3530 on the Blood Pressure of Patients With Hypertension Taking Amlodipine
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Mirodenafil (Primary) ; Amlodipine
- Indications Hypertension
- Focus Pharmacodynamics
- Sponsors SK Chemicals
- 09 Mar 2013 Results presented at the 114th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
- 09 Mar 2013 Status changed from recruiting to completed.
- 19 Mar 2008 New trial record.